Procter & GamblePGBUY ON WEAKNESSApr 13, 2015Stock price when the opinion was issued
As of Jun 08, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
Share price has been quite weak with the move upwards in the US$. They have significant businesses outside of the US. However, when you have a temporary move and divergence in currencies in a short period of time, it can create opportunities to buy very high quality companies, at a slightly depressed price. Trading at about 20 X earnings, so not cheap. If it pulls back a lot from where it is, it would be a pretty good buying opportunity. 3% dividend yield.